Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections

Matthew K. Tollefson, Igor Frank, Matthew T. Gettman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: To determine the incidence and morbidity of surgical site infections (SSI) during prostatectomy, and determine the association with surgical approach. The development of a SSI after radical prostatectomy is associated with increased cost and significant morbidity. However, existing comparisons between open and robotic surgery have been made comparing a contemporary robotic experience with historical cohorts undergoing open surgery. Methods: We reviewed the incidence of SSI in 5908 consecutive patients undergoing both retropubic radical prostatectomy (RRP; n = 4824 [81.7%]) and robotic-assisted radical prostatectomy (RARP; n = 1084 [18.3%]) at our institution between 2004 and 2008. Patient records were reviewed for the development and treatment of an SSI, defined as wound erythema or cellulitis that necessitated antibiotic therapy or opening of the surgical wound within 30 days of surgery. Results: In total, 222 (3.7%) patients developed an SSI. Those undergoing RARP (6/1084, 0.6%) were significantly less likely to develop an SSI than patients undergoing RRP (216/4824, 4.5%) (P <.001). Furthermore, SSIs in patients undergoing RARP resolved more quickly (median, 7 vs 16 days) and were less likely to require wound incision and/or drainage (1 vs 84 patients), hospital readmission (0 vs 11 patients), or return to the operating room for debridement (0 vs 6 patients). Conclusions: Patients undergoing RARP are less likely to develop SSIs than patients undergoing RRP. Furthermore, the infections that develop after minimally invasive surgery are less severe. Continued investigation into the mechanisms of SSIs are needed to further decrease patient morbidity.

Original languageEnglish (US)
Pages (from-to)827-831
Number of pages5
JournalUrology
Volume78
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Surgical Wound Infection
Robotics
Prostatectomy
Morbidity
Incidence
Patient Readmission
Cellulitis
Minimally Invasive Surgical Procedures
Wounds and Injuries
Debridement
Operating Rooms
Erythema
Ambulatory Surgical Procedures
Drainage
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Urology

Cite this

Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections. / Tollefson, Matthew K.; Frank, Igor; Gettman, Matthew T.

In: Urology, Vol. 78, No. 4, 10.2011, p. 827-831.

Research output: Contribution to journalArticle

Tollefson, Matthew K. ; Frank, Igor ; Gettman, Matthew T. / Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections. In: Urology. 2011 ; Vol. 78, No. 4. pp. 827-831.
@article{aa216613389e4a15bb17cb61c7b585cd,
title = "Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections",
abstract = "Objective: To determine the incidence and morbidity of surgical site infections (SSI) during prostatectomy, and determine the association with surgical approach. The development of a SSI after radical prostatectomy is associated with increased cost and significant morbidity. However, existing comparisons between open and robotic surgery have been made comparing a contemporary robotic experience with historical cohorts undergoing open surgery. Methods: We reviewed the incidence of SSI in 5908 consecutive patients undergoing both retropubic radical prostatectomy (RRP; n = 4824 [81.7{\%}]) and robotic-assisted radical prostatectomy (RARP; n = 1084 [18.3{\%}]) at our institution between 2004 and 2008. Patient records were reviewed for the development and treatment of an SSI, defined as wound erythema or cellulitis that necessitated antibiotic therapy or opening of the surgical wound within 30 days of surgery. Results: In total, 222 (3.7{\%}) patients developed an SSI. Those undergoing RARP (6/1084, 0.6{\%}) were significantly less likely to develop an SSI than patients undergoing RRP (216/4824, 4.5{\%}) (P <.001). Furthermore, SSIs in patients undergoing RARP resolved more quickly (median, 7 vs 16 days) and were less likely to require wound incision and/or drainage (1 vs 84 patients), hospital readmission (0 vs 11 patients), or return to the operating room for debridement (0 vs 6 patients). Conclusions: Patients undergoing RARP are less likely to develop SSIs than patients undergoing RRP. Furthermore, the infections that develop after minimally invasive surgery are less severe. Continued investigation into the mechanisms of SSIs are needed to further decrease patient morbidity.",
author = "Tollefson, {Matthew K.} and Igor Frank and Gettman, {Matthew T.}",
year = "2011",
month = "10",
doi = "10.1016/j.urology.2011.05.037",
language = "English (US)",
volume = "78",
pages = "827--831",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections

AU - Tollefson, Matthew K.

AU - Frank, Igor

AU - Gettman, Matthew T.

PY - 2011/10

Y1 - 2011/10

N2 - Objective: To determine the incidence and morbidity of surgical site infections (SSI) during prostatectomy, and determine the association with surgical approach. The development of a SSI after radical prostatectomy is associated with increased cost and significant morbidity. However, existing comparisons between open and robotic surgery have been made comparing a contemporary robotic experience with historical cohorts undergoing open surgery. Methods: We reviewed the incidence of SSI in 5908 consecutive patients undergoing both retropubic radical prostatectomy (RRP; n = 4824 [81.7%]) and robotic-assisted radical prostatectomy (RARP; n = 1084 [18.3%]) at our institution between 2004 and 2008. Patient records were reviewed for the development and treatment of an SSI, defined as wound erythema or cellulitis that necessitated antibiotic therapy or opening of the surgical wound within 30 days of surgery. Results: In total, 222 (3.7%) patients developed an SSI. Those undergoing RARP (6/1084, 0.6%) were significantly less likely to develop an SSI than patients undergoing RRP (216/4824, 4.5%) (P <.001). Furthermore, SSIs in patients undergoing RARP resolved more quickly (median, 7 vs 16 days) and were less likely to require wound incision and/or drainage (1 vs 84 patients), hospital readmission (0 vs 11 patients), or return to the operating room for debridement (0 vs 6 patients). Conclusions: Patients undergoing RARP are less likely to develop SSIs than patients undergoing RRP. Furthermore, the infections that develop after minimally invasive surgery are less severe. Continued investigation into the mechanisms of SSIs are needed to further decrease patient morbidity.

AB - Objective: To determine the incidence and morbidity of surgical site infections (SSI) during prostatectomy, and determine the association with surgical approach. The development of a SSI after radical prostatectomy is associated with increased cost and significant morbidity. However, existing comparisons between open and robotic surgery have been made comparing a contemporary robotic experience with historical cohorts undergoing open surgery. Methods: We reviewed the incidence of SSI in 5908 consecutive patients undergoing both retropubic radical prostatectomy (RRP; n = 4824 [81.7%]) and robotic-assisted radical prostatectomy (RARP; n = 1084 [18.3%]) at our institution between 2004 and 2008. Patient records were reviewed for the development and treatment of an SSI, defined as wound erythema or cellulitis that necessitated antibiotic therapy or opening of the surgical wound within 30 days of surgery. Results: In total, 222 (3.7%) patients developed an SSI. Those undergoing RARP (6/1084, 0.6%) were significantly less likely to develop an SSI than patients undergoing RRP (216/4824, 4.5%) (P <.001). Furthermore, SSIs in patients undergoing RARP resolved more quickly (median, 7 vs 16 days) and were less likely to require wound incision and/or drainage (1 vs 84 patients), hospital readmission (0 vs 11 patients), or return to the operating room for debridement (0 vs 6 patients). Conclusions: Patients undergoing RARP are less likely to develop SSIs than patients undergoing RRP. Furthermore, the infections that develop after minimally invasive surgery are less severe. Continued investigation into the mechanisms of SSIs are needed to further decrease patient morbidity.

UR - http://www.scopus.com/inward/record.url?scp=80053892660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053892660&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2011.05.037

DO - 10.1016/j.urology.2011.05.037

M3 - Article

VL - 78

SP - 827

EP - 831

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -